Oxford University Takes More Time for Anti - Inocation COVID-19

The candidate vaccine to combat the Coronavirus, developed by Oxford University, in collaboration with the IRBM and Pomese, needs further studies. The news was delivered by Pascal Sorio, the number one of the pharmaceutical companies AstraZeneca, who is partners in the project. This bad news at this moment of pandemic comes days [...]
The candidate vaccine to combat the Coronavirus, developed by Oxford University, in collaboration with the IRBM and Pomese, needs further studies.
The news was delivered by Pascal Sorio, the number one of the pharmaceutical companies AstraZeneca, who is partners in the project.
This bad news at this moment of pandemic comes several days after announcing the results of clinical trials by Oxford University showing that their prototype vaccine had an efficiency of over 90% against Coronobritus.












